After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Now, it’s worth noting Stock Advisor’s total average return is 968 % — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

Indian speciality pharmaceutical firm Ajanta Pharma is understood to be eyeing a manufacturing operation in Ireland. The ...

The University of Pennsylvania, biotech firm BioNTech, and Osage University Partners, a venture capital firm in Bala Cynwyd, ...

Congressional inaction has led to the expiration of the federal government’s SBIR/STTR program, cutting off a biotechnology ...

Source: Strategic partnerships to inject life into medicines production | The Herald (Top Stories) Rumbidzayi Zinyuke Senior Health Reporter Zimbabwe has intensified efforts to revive its ...

This line of argument could resonate with other conservative groups in the European Parliament opposed to abortion ...

HANGZHOU, China, SHANGHAI and BOSTON, Jan. 12, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical stage innovative drug development ...

Run by Roger Perlmutter and backed by more than $1 billion in private funding, Eikon will use the IPO proceeds to advance a ...

Stoke Therapeutics and the FDA were unable to reach agreement on an expedited submission for the company’s severe epilepsy ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

This clinical-stage biotech specializing in antibody therapeutics reported a notable insider sale amid ongoing development and partnerships.